harte-hanks inc. - HHS

HHS

Close Chg Chg %
2.34 -0.02 -0.85%

Closed Market

2.32

-0.02 (0.85%)

Volume: 259.62

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Company Overview: harte-hanks inc. - HHS

HHS Key Data

Open

$2.42

Day Range

2.32 - 2.50

52 Week Range

2.22 - 5.39

Market Cap

$18.54M

Shares Outstanding

7.41M

Public Float

5.90M

Beta

-0.14

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.11

Yield

0.00%

Dividend

$0.09

EX-DIVIDEND DATE

Feb 26, 2016

SHORT INTEREST

N/A

AVERAGE VOLUME

4.26K

 

HHS Performance

1 Week
 
5.49%
 
1 Month
 
-10.07%
 
3 Months
 
-18.30%
 
1 Year
 
-47.81%
 
5 Years
 
-43.18%
 

HHS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About harte-hanks inc. - HHS

Harte-Hanks, Inc. is a global customer experience company operating in three business segments: Marketing Services, Customer Care, and Fulfillment & Logistics Services. The company's mission is to partner with clients to provide them with a robust customer-experience, or CX, strategy, data-driven analytics and actionable insights combined with seamless program execution to better understand, attract, and engage their customers. Its services include strategic planning, data strategy, performance analytics, creative development, and execution, technology enablement, marketing automation, B2B and B2C e-commerce, cross-channel customer care, and product, print, and mail fulfillment. The company was founded in 1923 and is headquartered in Chelmsford, MA.

HHS At a Glance

Harte-Hanks, Inc.
1 Executive Drive
Chelmsford, Massachusetts 01824
Phone 1-512-434-1100 Revenue 159.57M
Industry Miscellaneous Commercial Services Net Income -811,000.00
Sector Commercial Services Employees 1,719
Fiscal Year-end 12 / 2026
View SEC Filings

HHS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.139
Price to Book Ratio 1.087
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 5.884
Enterprise Value to Sales 0.245
Total Debt to Enterprise Value 0.573

HHS Efficiency

Revenue/Employee 92,827.225
Income Per Employee -471.786
Receivables Turnover 4.574
Total Asset Turnover 1.483

HHS Liquidity

Current Ratio 1.536
Quick Ratio 1.536
Cash Ratio 0.185

HHS Profitability

Gross Margin 15.277
Operating Margin 1.359
Pretax Margin -0.632
Net Margin -0.508
Return on Assets -0.754
Return on Equity -3.842
Return on Total Capital -1.889
Return on Invested Capital -1.98

HHS Capital Structure

Total Debt to Total Equity 109.149
Total Debt to Total Capital 52.187
Total Debt to Total Assets 21.891
Long-Term Debt to Equity 91.888
Long-Term Debt to Total Capital 43.934
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Harte-hanks Inc. - HHS

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
206.28M 191.49M 185.24M 159.57M
Sales Growth
+6.00% -7.17% -3.26% -13.86%
Cost of Goods Sold (COGS) incl D&A
173.20M 161.77M 154.80M 135.19M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.73M 4.24M 4.38M 4.47M
Depreciation
2.73M 3.40M 3.50M 4.10M
Amortization of Intangibles
- 837.00K 885.00K 372.00K
COGS Growth
+6.43% -6.60% -4.31% -12.66%
Gross Income
33.08M 29.72M 30.44M 24.38M
Gross Income Growth
+3.83% -10.15% +2.44% -19.93%
Gross Profit Margin
+16.04% +15.52% +16.43% +15.28%
2022 2023 2024 2025 5-year trend
SG&A Expense
17.97M 20.67M 22.78M 22.21M
Research & Development
- - - -
-
Other SG&A
17.97M 20.67M 22.78M 22.21M
SGA Growth
+0.63% +15.04% +10.20% -2.51%
Other Operating Expense
- - - -
-
Unusual Expense
- 5.69M 43.08M 1.78M
EBIT after Unusual Expense
15.11M 3.36M (35.41M) 386.00K
Non Operating Income/Expense
4.64M (5.28M) (2.33M) (1.15M)
Non-Operating Interest Income
- - - 135.00K
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 438.00K 187.00K 248.00K
Interest Expense Growth
- - -51.50% +32.62%
-
Gross Interest Expense
- 438.00K 187.00K 248.00K
Interest Capitalized
- - - -
-
Pretax Income
19.31M (1.92M) (37.93M) (1.01M)
Pretax Income Growth
+18.78% -109.94% -1,876.76% +97.34%
Pretax Margin
+9.36% -1.00% -20.48% -0.63%
Income Tax
(17.46M) (349.00K) (7.64M) (197.00K)
Income Tax - Current - Domestic
834.00K 254.00K 428.00K 288.00K
Income Tax - Current - Foreign
1.55M 871.00K 1.21M 443.00K
Income Tax - Deferred - Domestic
(19.84M) (1.56M) (9.18M) (957.00K)
Income Tax - Deferred - Foreign
- 82.00K (104.00K) 29.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
36.78M (1.57M) (30.30M) (811.00K)
Minority Interest Expense
- - - -
-
Net Income
36.78M (1.57M) (30.30M) (811.00K)
Net Income Growth
+180.45% -104.27% -1,829.75% +97.32%
Net Margin Growth
+17.83% -0.82% -16.36% -0.51%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
36.78M (1.57M) (30.30M) (811.00K)
Preferred Dividends
- - - 1.38M
-
Net Income Available to Common
35.40M (1.57M) (30.30M) (811.00K)
EPS (Basic)
4.9846 -0.2148 -4.1543 -0.1097
EPS (Basic) Growth
+168.73% -104.31% -1,834.03% +97.36%
Basic Shares Outstanding
7.10M 7.31M 7.29M 7.39M
EPS (Diluted)
4.7467 -0.2148 -4.1543 -0.1097
EPS (Diluted) Growth
+171.21% -104.53% -1,834.03% +97.36%
Diluted Shares Outstanding
7.46M 7.31M 7.29M 7.39M
EBITDA
17.84M 13.28M 12.05M 6.64M
EBITDA Growth
+7.72% -25.52% -9.30% -44.89%
EBITDA Margin
+8.65% +6.94% +6.50% +4.16%

Insider Actions for Harte-hanks Inc. - HHS

Date Name Shares Transaction Value
Dec 16, 2025 Genevieve Claire Combes Director 27,861 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $3.23 per share 89,991.03

Harte-Hanks Inc. in the News